Calidad de la información sobre productos médicos ilegales: clave para proteger la salud pública. [PDF]
Alfonso Arvez MJ +9 more
europepmc +1 more source
[Characterization of occupational risks in workers affiliated to the IMSS 2024]. [PDF]
Velázquez-Narváez Y +3 more
europepmc +1 more source
[Clinical profile of patients with secondary immunodeficiency on immunoglobulin replacement therapy]. [PDF]
Méndez-Gómez A +7 more
europepmc +1 more source
[Advantages and disadvantages of mandatory compliance with the official vaccination schedule]. [PDF]
Javierre Miranda AP +2 more
europepmc +1 more source
[Substandard and falsified medical products: 25 years of successful network collaboration among regulatory authorities in the AmericasProdutos médicos de qualidade inferior e falsificados: 25 anos de colaboração bem-sucedida em rede entre autoridades reguladoras da Região das Américas]. [PDF]
Vahos Zambrano J +9 more
europepmc +1 more source
Nicotine e-cigarettes in Peru: analysis of law 32159 against international evidence and gaps for adolescent protection. [PDF]
Chirinos-Caceres J +3 more
europepmc +1 more source
Expert consensus on vaccination as a primary prevention strategy for women of reproductive age, pregnant, or adulthood [PDF]
Miranda Quintero J +8 more
europepmc +1 more source
[Risk factors associated with inadequacy of empirical treatment in patients with sepsis and bacteremia attended in an emergency department]. [PDF]
Motos-Bescós M +6 more
europepmc +1 more source
Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]
Panesso GA +7 more
europepmc +1 more source
[Nirsevimab immunization effectiveness against respiratory syncytial virus hospitalization in newborns: two season of use in Navarre, Spain]. [PDF]
Vera-Punzano N +11 more
europepmc +1 more source

